Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the immunological response to a booster dose of GSK Biologicals’ IPV in terms of poliovirus type 1, 2 and 3 antibodies, one month after the booster dose in subjects primed with three doses of the same IPV vaccine in study IPV-018. To assess the persistence of antibodies to poliovirus types 1, 2 and 3 antigens at 18 months of age in subjects primed with three doses of GSK Biologicals’ IPV or three doses of OPV in study IPV-018.
Critère d'inclusion
- Booster immunisation of healthy children in the second year of life against poliomyelitis